Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 103113 | 120.25 |
09:34 ET | 38732 | 120.49 |
09:36 ET | 38585 | 121.5297 |
09:38 ET | 35879 | 122.3 |
09:39 ET | 19586 | 122.91 |
09:41 ET | 33046 | 122.72 |
09:43 ET | 38906 | 122.08 |
09:45 ET | 15577 | 122.425 |
09:48 ET | 7972 | 122.76 |
09:50 ET | 30727 | 122.91 |
09:52 ET | 61576 | 123.35 |
09:54 ET | 23622 | 122.54 |
09:56 ET | 7011 | 122.38 |
09:57 ET | 16011 | 122.04 |
09:59 ET | 15996 | 121.94 |
10:01 ET | 11007 | 122.3001 |
10:03 ET | 14867 | 121.1 |
10:06 ET | 38369 | 120.37 |
10:08 ET | 28935 | 120.135 |
10:10 ET | 13028 | 120.065 |
10:12 ET | 13497 | 119.53 |
10:14 ET | 19674 | 119.19 |
10:15 ET | 17703 | 119.37 |
10:17 ET | 9270 | 119.155 |
10:19 ET | 16067 | 119.9 |
10:21 ET | 15598 | 119.51 |
10:24 ET | 19841 | 119.81 |
10:26 ET | 9145 | 119.46 |
10:28 ET | 12002 | 119.74 |
10:30 ET | 8673 | 119.575 |
10:32 ET | 13353 | 119.255 |
10:33 ET | 9533 | 119.34 |
10:35 ET | 7616 | 119.0248 |
10:37 ET | 9789 | 118.56 |
10:39 ET | 11753 | 118.51 |
10:42 ET | 5104 | 118.27 |
10:44 ET | 5307 | 118.44 |
10:46 ET | 7412 | 118.4 |
10:48 ET | 9552 | 118.245 |
10:50 ET | 23801 | 117.75 |
10:51 ET | 42245 | 117.75 |
10:53 ET | 18555 | 117.4668 |
10:55 ET | 21106 | 117.37 |
10:57 ET | 14924 | 117.185 |
11:00 ET | 8527 | 117.59 |
11:02 ET | 15817 | 117.79 |
11:04 ET | 8976 | 117.74 |
11:06 ET | 9930 | 117.79 |
11:08 ET | 9379 | 117.87 |
11:09 ET | 9017 | 117.965 |
11:11 ET | 4071 | 118.205 |
11:13 ET | 6970 | 117.715 |
11:15 ET | 12201 | 117.68 |
11:18 ET | 7131 | 118.52 |
11:20 ET | 22428 | 118.615 |
11:22 ET | 5442 | 118.31 |
11:24 ET | 5750 | 118.29 |
11:26 ET | 4796 | 118.48 |
11:27 ET | 7801 | 117.89 |
11:29 ET | 4228 | 117.8436 |
11:31 ET | 3272 | 117.5801 |
11:33 ET | 5963 | 117.79 |
11:36 ET | 4667 | 117.7907 |
11:38 ET | 2452 | 117.54 |
11:40 ET | 6189 | 117.88 |
11:42 ET | 16361 | 117.5 |
11:44 ET | 9331 | 117.505 |
11:45 ET | 25125 | 117.52 |
11:47 ET | 10218 | 117.56 |
11:49 ET | 16533 | 117.5275 |
11:51 ET | 8088 | 117.505 |
11:54 ET | 14301 | 117.33 |
11:56 ET | 7026 | 117.32 |
11:58 ET | 3617 | 117.2674 |
12:00 ET | 8675 | 117.47 |
12:02 ET | 9994 | 117.4 |
12:03 ET | 12922 | 117.27 |
12:05 ET | 1210 | 117.44 |
12:07 ET | 2880 | 117.5 |
12:09 ET | 6201 | 117.58 |
12:12 ET | 10202 | 117.5 |
12:14 ET | 7035 | 117.28 |
12:16 ET | 1060 | 117.17 |
12:18 ET | 6149 | 117.03 |
12:20 ET | 17120 | 116.7501 |
12:21 ET | 10982 | 116.57 |
12:23 ET | 3930 | 116.545 |
12:25 ET | 27205 | 116.31 |
12:27 ET | 9027 | 116.325 |
12:30 ET | 5935 | 116.57 |
12:32 ET | 4797 | 116.24 |
12:34 ET | 6953 | 116.36 |
12:36 ET | 5104 | 116.15 |
12:38 ET | 7332 | 116.1 |
12:39 ET | 4530 | 116.17 |
12:41 ET | 5405 | 116.16 |
12:43 ET | 10332 | 116.08 |
12:45 ET | 3335 | 116 |
12:48 ET | 3455 | 116.02 |
12:50 ET | 2905 | 116.062 |
12:52 ET | 5203 | 116.07 |
12:54 ET | 3874 | 116.24 |
12:56 ET | 3121 | 116.205 |
12:57 ET | 2007 | 116.1927 |
12:59 ET | 7100 | 116.075 |
01:01 ET | 2502 | 115.995 |
01:03 ET | 12338 | 115.94 |
01:06 ET | 9094 | 115.975 |
01:08 ET | 5461 | 115.87 |
01:10 ET | 7944 | 115.725 |
01:12 ET | 3950 | 115.61 |
01:14 ET | 1800 | 115.81 |
01:15 ET | 5709 | 115.84 |
01:17 ET | 6199 | 115.695 |
01:19 ET | 4843 | 115.93 |
01:21 ET | 5762 | 115.765 |
01:24 ET | 3540 | 115.62 |
01:26 ET | 4750 | 115.76 |
01:28 ET | 2940 | 115.86 |
01:30 ET | 5504 | 115.805 |
01:32 ET | 5180 | 115.82 |
01:33 ET | 4574 | 115.68 |
01:35 ET | 4422 | 115.755 |
01:37 ET | 3032 | 115.76 |
01:39 ET | 20337 | 115.85 |
01:42 ET | 3503 | 115.82 |
01:44 ET | 1334 | 115.82 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 45.5B | -7.4x | --- |
ICON PLC | 25.9B | 38.4x | +4.68% |
Biogen Inc | 33.8B | 28.9x | -18.14% |
Biontech SE | 19.1B | 154.6x | --- |
Grifols SA | 5.2B | 20.8x | --- |
Alnylam Pharmaceuticals Inc | 30.7B | -90.2x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $45.5B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.65 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -7.4x |
Price/Sales (TTM) | 8.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.